The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib

Di Vito, A; Ravegnini, G; Gorini, F; Aasen, T; Serrano, C; Benuzzi, E; Coschina, E; Monesmith, S; Morroni, F; Angelini, S; Hrelia, P

Angelini, S (通讯作者)，Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.

PHARMACOLOGY & THERAPEUTICS, 2023; 248 ():

Abstract

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal sarcomas and the gold-standard treatment is rep-resented by tyrosine kinase inhibitors (T......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索